New approaches to modeling bipolar disorder.

Area of Science:

• Neuroscience
• Psychiatry
• Pharmacology

Background:

• Animal models are essential for studying human disease pathophysiology and therapy development.
• Validation of these models relies on face, predictive, and construct validity.
• Existing psychiatric disorder models often originate from face validity, observing similar rodent and human behaviors.

Purpose of the Study:

• Critically appraise current animal models for bipolar disorder, detailing their strengths and limitations.
• Discuss technological advancements influencing the understanding of bipolar disorder's pathophysiology and treatment.
• Highlight new construct validity-driven models for bipolar disorder.

Main Methods:

• Review and critical appraisal of existing animal models for bipolar disorder.
• Discussion of technological advances in understanding signal transduction and neurotrophic cascades.
• Examination of new construct validity-driven models targeting specific signaling pathways.

Main Results:

• Existing models, often based on face validity, have limitations.
• Technological advances reveal the importance of signal transduction and neurotrophic cascades.
• New models targeting G proteins, phosphoinositide signaling, and MAP kinase cascades are promising.

Conclusions:

• New construct validity-driven animal models offer significant potential for understanding bipolar disorder.
• These advanced models are key to developing novel and improved therapeutics for bipolar disorder.
• Further research into signaling pathways is crucial for advancing bipolar disorder treatment.